CUNEO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.006
AS - Asia 988
EU - Europa 564
SA - Sud America 53
AF - Africa 49
Totale 2.660
Nazione #
US - Stati Uniti d'America 996
SG - Singapore 313
VN - Vietnam 269
CN - Cina 227
GB - Regno Unito 135
IT - Italia 94
SE - Svezia 85
HK - Hong Kong 58
DE - Germania 56
IN - India 41
FR - Francia 39
NL - Olanda 39
BR - Brasile 37
IE - Irlanda 32
RU - Federazione Russa 27
JP - Giappone 23
TG - Togo 15
ZA - Sudafrica 15
EE - Estonia 12
PH - Filippine 11
AR - Argentina 10
CH - Svizzera 9
CA - Canada 7
CI - Costa d'Avorio 7
UA - Ucraina 7
JO - Giordania 6
BD - Bangladesh 5
BG - Bulgaria 5
FI - Finlandia 5
QA - Qatar 5
EC - Ecuador 4
ES - Italia 4
GR - Grecia 4
KR - Corea 4
TH - Thailandia 4
TN - Tunisia 4
TW - Taiwan 4
AT - Austria 3
IQ - Iraq 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
EG - Egitto 2
ID - Indonesia 2
IR - Iran 2
MA - Marocco 2
MX - Messico 2
NG - Nigeria 2
PK - Pakistan 2
RS - Serbia 2
TR - Turchia 2
UZ - Uzbekistan 2
AL - Albania 1
CL - Cile 1
CO - Colombia 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
PL - Polonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
Totale 2.660
Città #
Singapore 185
Southend 122
Ashburn 104
Santa Clara 96
Fairfield 76
San Jose 71
Chandler 63
Ho Chi Minh City 62
Beijing 57
Hong Kong 56
Hanoi 51
Houston 42
Seattle 40
Los Angeles 33
Dong Ket 32
Dublin 32
Woodbridge 32
Wilmington 28
Boardman 27
Cambridge 27
Ann Arbor 25
Princeton 24
Tokyo 16
Lauterbourg 15
Lomé 15
New York 15
Bologna 14
Nanjing 13
Bremen 12
Buffalo 12
Padova 12
Westminster 12
Da Nang 8
Rome 8
Turin 8
Abidjan 7
Guangzhou 7
Jinan 7
Saint Petersburg 7
Shenyang 7
Amman 6
Berlin 6
Chicago 6
Frankfurt am Main 6
Haiphong 6
Wuhan 6
Biên Hòa 5
Doha 5
Florence 5
Hebei 5
Medford 5
Milan 5
Norwalk 5
Rimini 5
San Diego 5
São Paulo 5
Zhengzhou 5
Bern 4
Hyderabad 4
London 4
Nanchang 4
Shenzhen 4
Sofia 4
Tianjin 4
Athens 3
Atlanta 3
Baghdad 3
Bangkok 3
Chennai 3
Hefei 3
Helsinki 3
Hải Dương 3
Johannesburg 3
Long Xuyen 3
Redondo Beach 3
Redwood City 3
Torino 3
Toronto 3
Vellore 3
Vĩnh Long 3
Abeokuta 2
Andover 2
Belo Horizonte 2
Bhopal 2
Brooklyn 2
Brussels 2
Bühl 2
Changsha 2
Dallas 2
Falls Church 2
Langfang 2
Lanzhou 2
Latina 2
Madrid 2
Manila 2
Nuremberg 2
Olalla 2
Orem 2
Parma 2
Quito 2
Totale 1.687
Nome #
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 209
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 209
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 207
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study 204
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 170
HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408 154
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. 153
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 142
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 140
Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408 136
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 134
Sequential use of first and second generation TKIs are effective on prolonged overall survival in elderly population affected by Ph+ acute lymphoblastic leukemia: the GIMEMA experience 127
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 67
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 63
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 58
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 56
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 55
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders 53
Cellule staminali circolanti in pazienti con infarto miocardico 53
Cellule staminali circolanti in pazienti con infarto miocardico 52
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 46
Cytogenetic aspects of B- cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens 45
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 40
Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases 38
Studio dei progenitori emopoietici e delle cellule endoteliali in cors di patologie autoimmuni: ruolo della citometria a flusso multicolore 35
Total loss of p53 DNA sequences in acute myeloid leukemia 31
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 29
Totale 2.706
Categoria #
all - tutte 7.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 6 9 80
2021/2022232 12 15 12 24 21 13 4 15 12 16 50 38
2022/2023306 21 36 14 40 17 22 7 28 57 38 18 8
2023/202496 1 21 14 12 13 13 7 2 5 5 2 1
2024/2025485 19 72 39 39 116 17 33 6 23 47 9 65
2025/2026944 82 88 79 39 144 51 73 43 275 70 0 0
Totale 2.706